Home > Healthcare > Medical Devices > Medical Supplies > pessary market
Get a free sample of Pessary Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Pessary Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The global pessary market size was valued at USD 447.5 million in 2024 and is projected to exhibit 4.8% CAGR from 2025 to 2034. The increasing prevalence of pelvic organ prolapse and urinary incontinence, growing awareness of the importance of timely diagnosis and treatment, rising adoption of non-invasive treatment options, and expanding government support for women's health programs are driving revenue growth in the market.
The aging global population is increasing the demand for non-surgical treatments like pessaries, as older adults are more prone to developing pelvic floor disorders such as pelvic organ prolapse and urinary incontinence. A study published in September 2022 by the National Center for Biotechnology Information revealed that approximately 40% of women worldwide experience pelvic organ prolapse, a figure expected to rise as the population continues to age. Additionally, a sedentary lifestyle and obesity can weaken the pelvic floor, further increasing the risk of prolapse and urinary incontinence in women.
Pessaries, medical devices inserted into the vagina, provide structural support to pelvic organs. They are commonly used to treat conditions like pelvic organ prolapse and stress urinary incontinence. Available in a variety of shapes and sizes, pessaries can be tailored to meet individual patient needs and address specific medical conditions.
The ring pessary segment held a 51.6% market share in 2024 due to its broad applicability for treating mild to moderate prolapse and stress urinary incontinence, making it suitable for a wide patient population.
The global pessary industry was valued at USD 447.5 million in 2024 and is projected to grow at a 4.8% CAGR from 2025 to 2034, driven by the increasing prevalence of pelvic organ prolapse and urinary incontinence.
The U.S. pessary market generated approximately USD 169.7 million in 2024, driven by the high prevalence of pelvic disorders and the demand for non-invasive treatment options for women.
Key players in the market include Artisan Medical, Bioteque America, Bliss GVS Pharma, Bray Group (Ethos Partners), Coloplast Group, Contiform International, CooperSurgical, Dr. Arabin, Integra Lifesciences, MedGyn Products, Novomed group (Gyneas), Panpac Medical, and Personal Medical.